BeiGene - Health Technology Insights

nference and BeiGene Collaborate to Drive New B-Cell Cancer Research

April 17, 2025

Real-world data study aims to improve treatment options for chronic lymphocytic leukemia and small lymphocytic lymphoma patients nference, a company dedicated to transforming healthcare by

ImmunityBio Announces Collaboration with BeiGene

ImmunityBio & BeiGene Collaborate on Phase 3 ANKTIVA Trial

January 30, 2025

ImmunityBio, announced it has entered into a collaboration and supply agreement with BeiGene, (to be changed to BeOne Medicines, Ltd.), a global oncology company, to

Categories

Tag: BeiGene

nference and BeiGene Collaborate to Drive New B-Cell Cancer Research

ImmunityBio & BeiGene Collaborate on Phase 3 ANKTIVA Trial

Share With

Recent Posts

MeMed BV Hits 100K Tests with Rapid Diagnostics

Tracer, QIAGEN Partner on Blood-Based MRD Test for Tumors

NextGen Healthcare Adds MDP as Investor, Plans Leadership Shift

JCR Pharma Launches Unique Global Site for 50th Anniversary

3 New Members Join Southern Nevada’s Top Regional Board

Quick Links

Insights

Get in touch

Follow Us

Our Other Brands